(Q43664066)

25 November 2017

title

Effects of low doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol levels in patients with hypercholesterolemia (English)

1 reference

25 November 2017

0 references

1 reference

Branchi A

1

1 reference

25 November 2017

Fiorenza AM

2

1 reference

25 November 2017

Torri A

3

1 reference

25 November 2017

Muzio F

4

1 reference

25 November 2017

Berra C

5

1 reference

25 November 2017

Colombo E

6

1 reference

25 November 2017

Dalla Valle E

7

1 reference

25 November 2017

Rovellini A

8

1 reference

25 November 2017

Sommariva D

9

1 reference

25 November 2017

publication date

1 June 2001

1 reference

25 November 2017

published in

Clinical Therapeutics

1 reference

25 November 2017

volume

23

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

851-857

1 reference

Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980073-4

7 January 2021

Clinical lipidology at the end of the millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980073-4

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980073-4

7 January 2021

Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT]).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980073-4

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980073-4

7 January 2021

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980073-4

7 January 2021

Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980073-4

7 January 2021

A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980073-4

7 January 2021

Comparison of the efficacy and tolerability of simvastatin and atorvastatin in the treatment of hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980073-4

7 January 2021

Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980073-4

7 January 2021

High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980073-4

7 January 2021

10.1016/S0149-2918(01)80073-4

Identifiers

DOI

1 reference

25 November 2017

1 reference